logo
  Join        Login             Stock Quote

Coca-Cola (KO) Earnings Rise 13 Pct, Revenue Lags In 4Q

 February 12, 2013 07:53 AM
 


(By Balachander) Coca-Cola Co. (NYSE: KO) reported a 13 percent increase in quarterly profit, helped by global volume growth. Earnings also topped Wall Street projections, while revenue growth was slightly short of consensus.

On a comparable basis, earnings per share (EPS) rose 15.4 percent to 45 cents from 39 cents, and beat market expectations by a penny. Net earnings attributable to shareowners of Coca-Cola increased 13 percent to $1.86 billion.

Net operating revenue rose 4 percent to $11.45 billion, while Wall Street analysts' projected a growth of 4.60 percent. Global volume grew 3 percent for the fourth quarter with North America volume up 1 percent and international volume rising 4 percent.

[Related -Coca-Cola Company (KO) Dividend Stock Analysis]

Reported gross margin contracted to 59.6 percent from 60.1 percent. Adjusted gross margin also shrank to 60.2 percent from 60.3 percent.

"In a year marked by continued uncertainty in the global economy, we delivered solid volume, revenue and profit growth, and we realized further volume and value share gains in nonalcoholic ready-to-drink beverages," CEO Muhtar Kent said.

KO ended Monday's regular trading session at $38.61. The stock has been trading in the 52-week range between $33.71 and $40.67.

iOnTheMarket Premium
Advertisement

Advertisement


Post Comment -- Login is required to post message
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
 

rss feed

Latest Stories

article imageGreek Government Theatrics and Other Reruns

Greece has a new anti-austerity government, but a disorderly euro exit is as unlikely as read on...

article imageHedge Market Volatility: Buy This Dividend Aristocrat

When uncertainty reigns in the global economy, you can count on stocks to be even more read on...

article imageCanadian Banks Hesitate to Follow the Bank of Canada's Rate Cut

The Bank of Canadasurprised markets last week when they lowered the overnight rate 0.75% on Wednesday. The read on...

article image3 Stocks With 100% Upside

Biotech stocks had a banner year in 2014. Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), Avanir read on...

Advertisement
Popular Articles

Advertisement
Daily Sector Scan
Partner Center



Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.